MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?
Profile
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.82M
P/E Ratio
N/A
Total Cash
7.2M
Projected Growth
N/A
Total Debt
3.4M
Revenue
190K
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
0.11
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
AIM
Capitalization
12.8M
P/E Ratio
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash
7.2M
Total Cash/Share
0.11
Total Debt
3.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
190K
ROE
N/A
Book Value
2.91M
P/B Ratio
4.40
Cash Flow
N/A
Earnings
-0.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
59K
Current Ratio
0.75
Current Revenue Per Employee
1250.00
Dividends Per Share - Security
N/A
EBITDA
-26.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.14
Revenue To Assets
-115.46
Shares Held By Institutions
3.06M
Shares Outstanding - Current
63.8M
Total Liabilities
10.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-54.308
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com